PSY10 Incidence and Prevalence of Idiopathic Inflammatory Myopathies Among Commercially Insured, Medicare Supplemental Insured, and Medicaid Enrolled Populations
نویسندگان
چکیده
منابع مشابه
Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis
BACKGROUND Idiopathic inflammatory myopathies (IIMs) are a rare group of autoimmune syndromes characterized by chronic muscle inflammation and muscle weakness with no known cause. Little is known about their incidence and prevalence. This study reports the incidence and prevalence of IIMs among commercially insured and Medicare and Medicaid enrolled populations in the US. METHODS We retrospec...
متن کاملRates and predictors of 30-day readmission among commercially insured and Medicaid-enrolled patients hospitalized with systolic heart failure.
BACKGROUND Heart failure (HF) readmission rates are primarily derived from Medicare enrollees. Given increasing public scrutiny of HF readmissions, understanding the rate and predictors in populations covered by other payers is also important, particularly among patients with systolic dysfunction, for whom most HF-specific therapies are targeted. METHODS AND RESULTS MarketScan Commercial and ...
متن کاملBurden of vaccine-preventable disease in adult Medicaid and commercially insured populations
Vaccination rates among United States (US) adults are suboptimal, resulting in morbidity, mortality, and financial burden attributable to potentially vaccine-preventable diseases (VPDs). Unadjusted annual incidence proportions of VPDs were estimated for Medicaid and commercially insured adults aged 19-64 years using 2006-2010 claims, along with age/gender-adjusted incidence proportions for 2010...
متن کاملCost trends among commercially insured and Medicare Advantage-insured patients with chronic obstructive pulmonary disease: 2006 through 2009
BACKGROUND Few estimates of health care costs related to chronic obstructive pulmonary disease (COPD) are available regarding commercially insured patients in the United States. The aims of this retrospective observational analysis of administrative data were to describe and compare health care resource use and costs related to COPD in the United States for patients with commercial insurance or...
متن کامل915Is a hospital's surgical site infection rate among Medicare-insured patients a good indicator of outcome for commercially-insured patients?
patients a good indicator of outcome for commercially-insured patients? Michael S. Calderwood, MD, MPH; Ken Kleinman, ScD; Michael V. Murphy, BA; Deborah Yokoe, MD, MPH, FIDSA, FSHEA; Richard Platt, MD, MS; Susan S. Huang, MD, MPH, FIDSA; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA; Division of Infectious Diseases, Brigham and ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Value in Health
سال: 2012
ISSN: 1098-3015
DOI: 10.1016/j.jval.2012.03.544